PharmacoEconomics - Open : Impact Factor & More
eISSN: 2509-4254pISSN: 2509-4262
Open AccessShare this on:
Key Metrics
CiteScore 
2.9
H-Index
17
SJR
Q2Pharmacology
SNIP
0.78
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on PharmacoEconomics - Open
PharmacoEconomics - Open Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SPRINGER INT PUBL AG |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 2790 | USD 3490 | GBP 2390 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in PharmacoEconomics - Open ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in PharmacoEconomics - Open
Retractions of Health Economic Evaluations: A Systematic Review.
- 26 Dec 2025
- PharmacoEconomics - open
Potential Economic Value of Multi-cancer Early Detection Testing Under Differential Cost Trends for Cancer Screening and Management.
- 23 Dec 2025
- PharmacoEconomics - open
Economic Evaluation of NHS England's Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling.
- 18 Dec 2025
- PharmacoEconomics - open
Budget Impact of the LungFlag™ Predictive Risk Model for Lung Cancer Screening.
- 18 Dec 2025
- PharmacoEconomics - open
Use of Health State Utility Values in Cost-Utility Analyses of Selected Infectious Diseases in Aging Populations: A Systematic Review and Critical Appraisal.
- 16 Dec 2025
- PharmacoEconomics - open
Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Blood Cancers: An Updated Systematic Review.
- 15 Dec 2025
- PharmacoEconomics - open
Retractions of Health Economic Evaluations: A Systematic Review.
- 26 Dec 2025
- PharmacoEconomics - open
Potential Economic Value of Multi-cancer Early Detection Testing Under Differential Cost Trends for Cancer Screening and Management.
- 23 Dec 2025
- PharmacoEconomics - open
Economic Evaluation of NHS England's Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling.
- 18 Dec 2025
- PharmacoEconomics - open
Budget Impact of the LungFlag™ Predictive Risk Model for Lung Cancer Screening.
- 18 Dec 2025
- PharmacoEconomics - open
Use of Health State Utility Values in Cost-Utility Analyses of Selected Infectious Diseases in Aging Populations: A Systematic Review and Critical Appraisal.
- 16 Dec 2025
- PharmacoEconomics - open
Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Blood Cancers: An Updated Systematic Review.
- 15 Dec 2025
- PharmacoEconomics - open
FAQs on PharmacoEconomics - Open
How long has PharmacoEconomics - Open been actively publishing? 
What is the publishing frequency of PharmacoEconomics - Open?
How many articles did PharmacoEconomics - Open publish last year?
What is the eISSN & pISSN for PharmacoEconomics - Open?
What is Citescore for PharmacoEconomics - Open?
What is the H Index for PharmacoEconomics - Open ?
What is SNIP score for PharmacoEconomics - Open?
What is the SJR for PharmacoEconomics - Open?
Who is the publisher of PharmacoEconomics - Open?
